SXTC
China Sxt Pharmaceuticals, Inc.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · CN
$2.34
−3.90%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 0.10x
- Price / sales
- 2.88x
- Price / cash flow
- -0.77x
Enterprise value
- Enterprise value
- -$24.0M
- EV / sales
- -22.34x
- EV / EBITDA
- 3.43x
- EV / EBIT
- 3.36x
- Market cap
- $3.1M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Mar 1, 2026